Related Experiment Video

Updated: May 25, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Understanding the mechanisms of aromatase inhibitor resistance

William R Miller, Alexey A Larionov

    Breast Cancer Research : BCR
    |January 27, 2012
    PubMed

    Insights

    Aromatase inhibitors are key for breast cancer treatment, but resistance limits effectiveness. Understanding diverse resistance mechanisms is crucial for improving patient outcomes.

    Area of Science:

    • Oncology
    • Endocrinology
    • Molecular Biology

    Background:

    • Aromatase inhibitors (AIs) are vital in breast cancer therapy.
    • Resistance to AIs presents a significant challenge in patient management.

    Purpose of the Study:

    • To explore the multifaceted causes of resistance to aromatase inhibitors in breast cancer treatment.
    • To synthesize evidence from clinical and molecular studies regarding AI resistance.

    Main Methods:

    • Analysis of clinical data, including endocrine, molecular, and pathological measurements.
    • Review of clinical trials investigating AIs alone or in combination therapies.

    Main Results:

    • Identified inherent tumor insensitivity to estrogen as a resistance factor.
    • Highlighted ineffective aromatase inhibition and independent estrogen sources.
    • Noted activation of non-endocrine signaling pathways and enhanced cell survival.
    • Observed selection of hormone-insensitive clones during treatment.

    Conclusions:

    • Resistance to aromatase inhibitors is complex and multifactorial.
    • Diverse mechanisms contribute to treatment failure, necessitating further research into overcoming resistance.

    More Related Videos

    Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down08:59

    Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

    Published on: December 11, 2017

    Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models09:58

    Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

    Published on: December 9, 2016

    Related Concept Videos

    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

    Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

    Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
    Mechanism of Antibiotic Resistance in MRSA01:25

    Mechanism of Antibiotic Resistance in MRSA

    Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
    Development of Antibiotic Resistance01:30

    Development of Antibiotic Resistance

    Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...